• Publications
  • Influence
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial
Summary Background Randomised placebo-controlled trials have shown that daily oral pre-exposure prophylaxis (PrEP) with tenofovir–emtricitabine reduces the risk of HIV infection. However, thisExpand
  • 1,022
  • 57
  • PDF
British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2015
Writing Group Duncan Churchill, Chair, Royal Sussex County Hospital, Brighton, UK Laura Waters, Vice Chair, Mortimer Market Centre, London, UK Nadia Ahmed, Mortimer Market Centre, London, UK BrianExpand
  • 90
  • 4
  • PDF
Latent and subclinical tuberculosis in HIV infected patients: a cross-sectional study
BackgroundHIV and tuberculosis (TB) are commonly associated. Identifying latent and asymptomatic tuberculosis infection in HIV-positive patients is important in preventing death and morbidityExpand
  • 26
  • 3
CD4 counts and the risk of systemic non-Hodgkin’s lymphoma in individuals with HIV in the UK
This very large HIV-positive cohort study examines a number of variables that predispose to the development of lymphoma in the HAART era. Despite a declining incidence of lymphoma, the authors defineExpand
  • 57
  • 2
  • PDF
Raised intracranial pressure complicating cryptococcal meningitis: immune reconstitution inflammatory syndrome or recurrent cryptococcal disease?
We report the case of a patient with advanced HIV disease and cryptococcal meningitis, who after an initially good clinical and mycological response to systemic anti-fungal treatment developedExpand
  • 35
  • 2
Changes in the provision of post-exposure prophylaxis for HIV after sexual exposure following introduction of guidelines and publicity campaigns
In July 2004, British Association of Sexual Health and HIV (BASHH) published guidelines for post-exposure prophylaxis following sexual exposure (PEPSE) and the Terence Higgins Trust (THT) launched aExpand
  • 20
  • 2
Experiences of stigma and discrimination in social and healthcare settings among trans people living with HIV in the UK
ABSTRACT The People Living with HIV StigmaSurvey UK 2015 was a community led national survey investigating experiences of people living with HIV in the UK in the past 12 months. Participants aged 18Expand
  • 10
  • 1
Incorporating HIV/hepatitis B virus/hepatitis C virus combined testing into routine blood tests in nine UK Emergency Departments: the “Going Viral” campaign
Routine HIV screening is recommended in those UK hospitals and primary care settings where the HIV prevalence is > 0.2%. For hepatitis B virus (HBV) and hepatitis C virus (HCV), however, testing isExpand
  • 31
An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis
BackgroundPre-exposure prophylaxis (PrEP) has proven biological efficacy to reduce the sexual acquisition of the human immunodeficiency virus (HIV). The PROUD study found that PrEP conferred higherExpand
  • 29
  • PDF
The prevalence of hepatitis B infection in adults with no recognized increased risk of infection.
  • 10